How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from the European Association of Preventive Cardiology

Roberto F.E. Pedretti, Dominique Hansen, Marco Ambrosetti, Maria Back, Thomas Berger, Mariana Cordeiro Ferreira, Véronique Cornelissen, Constantinos H. Davos, Wolfram Doehner, Carmen de Pablo Y Zarzosa, Ines Frederix, Andrea Greco, Donata Kurpas, Matthias Michal, Elena Osto, Susanne S. Pedersen, Rita Esmeralda Salvador, Maria Simonenko, Patrizia Steca, David R. ThompsonMatthias Wilhelm, Ana Abreu

Research output: Contribution to journalArticlepeer-review

30 Citations (Scopus)

Abstract

A key factor to successful secondary prevention of cardiovascular disease (CVD) is optimal patient adherence to treatment. However, unsatisfactory rates of adherence to treatment for CVD risk factors and CVD have been observed consistently over the last few decades. Hence, achieving optimal adherence to lifestyle measures and guideline-directed medical therapy in secondary prevention and rehabilitation is a great challenge to many healthcare professionals. Therefore, in this European Association of Preventive Cardiology (EAPC) clinical consensus document a modern reappraisal of the adherence to optimal treatment is provided, together with simple, practical, and feasible suggestions to achieve this goal in the clinical setting, focusing on evidence-based concepts.

Original languageEnglish
Pages (from-to)149-166
Number of pages18
JournalEuropean Journal of Preventive Cardiology
Volume30
Issue number2
Early online date13 Sept 2022
DOIs
Publication statusPublished - 25 Jan 2023

Keywords

  • Adherence
  • Cardiovascular disease
  • Cardiovascular risk
  • Secondary prevention

ASJC Scopus subject areas

  • Epidemiology
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from the European Association of Preventive Cardiology'. Together they form a unique fingerprint.

Cite this